Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Expression of Hugl-1 is strongly reduced in malignant melanoma.

Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, Strand S, Strand D, Bosserhoff AK.

Oncogene. 2006 Jan 5;25(1):103-10.

PMID:
16170365
2.

Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer.

Schimanski CC, Schmitz G, Kashyap A, Bosserhoff AK, Bataille F, Schäfer SC, Lehr HA, Berger MR, Galle PR, Strand S, Strand D.

Oncogene. 2005 Apr 28;24(19):3100-9.

PMID:
15735678
3.

Expression of Dickkopf genes is strongly reduced in malignant melanoma.

Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH, Bosserhoff AK.

Oncogene. 2006 Aug 17;25(36):5027-36. Epub 2006 Mar 27.

PMID:
16568085
4.

Loss of nephronectin promotes tumor progression in malignant melanoma.

Kuphal S, Wallner S, Bosserhoff AK.

Cancer Sci. 2008 Feb;99(2):229-33. doi: 10.1111/j.1349-7006.2007.00678.x.

5.

Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE.

Int J Mol Med. 2006 Apr;17(4):583-90.

PMID:
16525713
6.
7.
8.

Cloning and characterization of the promoter of Hugl-2, the human homologue of Drosophila lethal giant larvae (lgl) polarity gene.

Zimmermann T, Kashyap A, Hartmann U, Otto G, Galle PR, Strand S, Strand D.

Biochem Biophys Res Commun. 2008 Feb 22;366(4):1067-73. Epub 2007 Dec 26.

PMID:
18155665
9.

Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer.

Tsuruga T, Nakagawa S, Watanabe M, Takizawa S, Matsumoto Y, Nagasaka K, Sone K, Hiraike H, Miyamoto Y, Hiraike O, Minaguchi T, Oda K, Yasugi T, Yano T, Taketani Y.

Oncol Res. 2007;16(9):431-5.

PMID:
18074678
10.

Differential regulation of Dlg1, Scrib, and Lgl1 expression in a transgenic mouse model of ocular cancer.

Vieira V, de la Houssaye G, Lacassagne E, Dufier JL, Jaïs JP, Beermann F, Menasche M, Abitbol M.

Mol Vis. 2008;14:2390-403. Epub 2008 Dec 19.

11.

The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo.

Grifoni D, Garoia F, Schimanski CC, Schmitz G, Laurenti E, Galle PR, Pession A, Cavicchi S, Strand D.

Oncogene. 2004 Nov 11;23(53):8688-94.

PMID:
15467749
12.

Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?

Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP.

Melanoma Res. 2001 Aug;11(4):355-69.

PMID:
11479424
13.

Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression.

Lu X, Feng X, Man X, Yang G, Tang L, Du D, Zhang F, Yuan H, Huang Q, Zhang Z, Liu Y, Strand D, Chen Z.

Clin Cancer Res. 2009 May 15;15(10):3287-96. doi: 10.1158/1078-0432.CCR-08-2078. Epub 2009 May 15. Erratum in: Clin Cancer Res. 2009 Jul 15;15(14):4786.

14.

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874. Epub 2008 Mar 7.

15.

Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (-)-epigallocatechin-3-gallate.

Wu Y, Lin Y, Liu H, Li J.

J Huazhong Univ Sci Technolog Med Sci. 2008 Jun;28(3):356-9. doi: 10.1007/s11596-008-0330-3. Epub 2008 Jun 19.

PMID:
18563342
16.

Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.

Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.

Oncogene. 2001 Jun 7;20(26):3363-75.

17.

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC.

BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20.

18.

Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.

Winklmeier A, Contreras-Shannon V, Arndt S, Melle C, Bosserhoff AK.

Cancer Sci. 2009 Feb;100(2):261-8. doi: 10.1111/j.1349-7006.2008.01048.x.

19.

Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.

Hata H, Kitamura T, Higashino F, Hida K, Yoshida K, Ohiro Y, Totsuka Y, Kitagawa Y, Shindoh M.

Oncol Rep. 2008 May;19(5):1093-8.

PMID:
18425363
20.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

Supplemental Content

Support Center